Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · IEX Real-Time Price · USD
1.060
-0.070 (-6.19%)
At close: Mar 28, 2024, 4:00 PM
1.050
-0.010 (-0.94%)
After-hours: Mar 28, 2024, 6:02 PM EDT

Quince Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020201920182017
Selling, General & Admin
26.0129.5217.598.952.031.27
Research & Development
25.1860.861.3130.2110.099.1
Other Operating Expenses
0.8300000
Operating Expenses
52.0290.3278.8939.1712.1210.37
Operating Income
-52.02-90.32-78.89-39.17-12.12-10.37
Interest Expense / Income
00000.961.64
Other Expense / Income
-0.64-0.37-2.04-2.19-0.60.22
Pretax Income
-51.38-89.95-76.85-36.98-12.48-12.24
Income Tax
0.2800000
Net Income
-51.66-89.95-76.85-36.98-12.48-12.24
Shares Outstanding (Basic)
3330291933
Shares Outstanding (Diluted)
3330291933
Shares Change
12.71%1.86%53.30%466.06%1.79%-
EPS (Basic)
-1.54-3.03-2.63-1.94-3.71-3.70
EPS (Diluted)
-1.54-3.03-2.63-1.94-3.71-3.70
Free Cash Flow
-44.1-63.11-50.87-33.33-11.91-9.9
Free Cash Flow Per Share
-1.32-2.12-1.74-1.75-3.54-3.00
EBITDA
-51.17-89.6-76.52-36.79-11.47-10.55
Depreciation & Amortization
0.20.340.330.190.050.05
EBIT
-51.38-89.95-76.85-36.98-11.52-10.59
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).